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Summary.-To determine whether myeloid leukaemic cells could inhibit normal
myeloid colony formation, leukaemic cells at concentrations ranging from 0 5 to
8 x 106/ml were co-cultured in agar but separated by a lml underlayer from l05 low-
density (< 1.077 g/ml) nonadherent normal marrow cells. Inhibition of normal-
marrow myeloid colony formation occurred regularly at high cell concentrations
(8 x106) at a leukaemic: normal cell ratio of 80:1. This suppression persisted with
addition of indomethacin (10-6M). On the other hand, both low leukaemic cell numbers
and irradiated leukaemic cells frequently stimulated normal colony growth. No
inhibitor of colony growth could be detected in leukaemic-conditioned media, and
absorption of colony-stimulating activity (CSA) with leukaemic cells improved CSA
activity. These experiments point tothe difficulty inunravelling the effect ofleukaemic
cells on normal haemopoiesis (both inhibitory and stimulatory) by in vitro agar
culture.
AT CLINICAL PRESENTATION, patients
with acute myeloid leukaemia (AML)
frequently have significant pancytopenia,
which persists until cytoreduction of
leukaemic cells produces remission. In
vitro cultures from AML patients on pre-
sentation show a lack ofdetectable normal
myeloid colony-forming cells (CFU-C,
early myeloid precursor cells) but early
return of CFU-C occurs in patients who
later achieve remission (Greenberg et al.,
1971; Moore et al., 1973, 1974; Senn et
al., 1967; Spitzer et al., 1976a, b, 1977).
In vitro cultures with glucose-6-phos-
phatedehydrogenase isozymes (Adamson,
1979; Fiaklow etal., 1979) andcytogenetics
(Moore & Metcalf, 1973) suggest that the
remission CFU-C are not leukaemic, but
normal in origin, though the in vitro
response to leukaemic soluble factors may
be abnormal (Broxmeyer et al., 1978a, b,
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1979). Suppression of normal in vitro
progenitor cells is not limited to myeloid
progenitor cells, as early progenitor cells
committed to erythropoiesis (the burst-
forming unit erythroids, BFU-E) are
reported to be decreased at diagnosis
(Fiaklow et al., 1979). A great deal of
research has focused on explaining the
suppression of granulopoiesis in myeloid
leukaemia, the absence of CFU-C on
presentation, and the reappearance of
normal CFU-C on remission.
Suppression of normal CFU-C by my-
eloid leukaemic cells by conditioned media
or by extracts has been shown by some
(Chiyoda et al., 1975, 1976; Craddock et al.,
1978; Gordon et al., 1978; Knudtson &
Mortenson, 1976; Morris et al., 1975) and
not by others (Bull et al., 1973; Greenberg
et al., 1971; Robinson et al., 1971). We
report here further experiments to try
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to definie possible interactions between
leukaemic cells and normal haemopoiesis.
The stimulatory and inhibitory effects
that were founcd will be presented and
discussed.
MATERIALS AND METHOD)S
The acquisition. collection, and preparation
of low-density (< 1-077 g/ml) nonadherent
normal or leukaemic cells from normal
volunteer.s or newly diagnosed leukaemie
patients have been described before (Spitzer
et al., 1979). The methods of cloning human
inyeloid progenitor cells have also been
described in detail (Spitzer et al., 1977).
Briefly, to measure the effects of leukaemic
cells on normal growth, leukaemic cells at
varying concentrations wvere placed in a
maximum volume of 0-1 ml on the bottom of
a 35mm tissue-culture plastic Petri dish. One
millilitre overlayer of0.5% agar, alpha modi-
fication of minimal essential media (x-MEM),
and 1500 foetal calf serum (FCS) with
0-2 ml of human placental-conditioned media
(HPCM) was then layered over the leukaemic
cells. Experiments in which the colony-
stimulating activity (CSA) of leukaemic cells
was also assessed did not include HPCM.
The low-density, nonadherent cells at a
concentration of 105/ml were theni cultured
above this underlayer in a mixture of 0-3%/
agar, o-MEM, and 15% FCS. The cultures
were scored for colonies (aggregates of >40
cells) and clusters (aggregates of 3-39 cells)
after 8 and 14 days of incubation in a fully
humidified atmosphere of 500 CO2 and air at
370C.
Cells wNere irradiated with 20 Gy from a
137Cs soiiice at a rate of 1-98 Gy/min. Cultures
including indomethacin were prepared by
adding a dilution of indomethacin from a
stock of 10-2M in distilled water and ethanol.
The final concentration of indomethacin was
10-6M. Ethanol at these concentrations or
indomethacin at 10-6M had no effect on
marrow colony formation.
Preparation and testing ofcontditionied media.
-Conditioned media wereprepared byadding
()5 x 106-8 x 106 leukaemie eells to 1 ml of
x-MEM and 15% FCS. Media were harvested
on Days 1-7, centrifuged at 800 g for 10 min,
filtered through a 0-22 Htm Millipore filter,
and stored at -200C until use. All conditioned
iiedia were thawAed only once and tested by
adding 0-2 ml to the 0-5/o agar layer containi-
ing HPCM. Some conditioned media included
phytohaemagglutinin (PHA) at a concentra-
tion of 4 Hug/ml of purified reagent (Bur-
roughs Welleome).
Absorption of conditioned media.-One-inl
volumes of HPCM were absorbed by adding
108 cells/ml of leukaemic cells, normal mar-
row%r cells, or peripheral-blood mononuclear
cells. Absorption was continued for 30 or
60 min. or overnight at 4°C. Some absorptions
wYere performed at 37TC.
RESULTS
Fig. I shows the results when graded
numbers of the same frozen-and-thawed
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FIG. 1. Inhibition of normal colony growth
by leukaemic-cell underlayers. Increasing
numbers of leukaemic cells from the same
patient were placed in 0o5% agar under-
layers with optimal quantities of human
placental-conditioned media. In the 033%
agar overlayer in 5 different experiments,
105 nonadherent low-density (< 1-077
g/ml) marrow cells from 5 normal donors
were cultured. Results are expressed as
the percentage change in colony growth of
the control (no leukaemic cells in the under-
layer). Results are the mean of triplicates.
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TABLE I. Unirradiated leukaemic cell modulation of CFU-C growth
f -
No.
leukaemic
cells
( x 106) HPCMI I
o) + .39+2
_ O
05 + 52±6
0
1.0 + 57 ±2
0
2-0 + 56±2
0
4-0 + 53+3
_ 0
8-0 + 18±6
- O
1+
lndo-
methacin
(10-6M) 2
39+2 112
59+ 11 59
- ()
(0 + 9
52 + 1
44+5
10+ 1
30
:
30
8
t Pure monocytic leukaemia.
I Mean + s.e.
leukaemic cells were added beneath under-
layers with optimal concentrations of
HPCM and 5 different marrow non-
adherent target cells (5 experiments) cul-
tured in the overlayers. At lower cell
concentrations (0.5 2 x 106 leukaemic cells)
there was a variable effect on normal
marrow growth, 3/5 experiments showing
increased growth. However, at a cell
concentration of 8 x 106, normal marrow
growth was always inhibited (50-82°O
inhibition, mean 68%).
Suppression did not appear to affect
any particular colony type, as results were
equivalent when cultures were scored on
Days 7 and 14. Examination of colony
morphology on Day 14 did not reveal
a differential suppression of eosinophil,
granulocyte, macrophage, or granulocyte-
macrophage colonies.
To further confirm that this inhibition
was not unique to the leukaemic cells
used in the initial experiments, further
experiments were performed with other
leukaemic-cell underlayers. Table I shows
the results of 6 such experiments. In 2
experiments (Expts 1-4) inhibition was
produced at only high cell numbers
(8 x 106) and in two other experiments
(2 and 3) at lower cell numbers of (0.5 x
106). Two cases of pure monocvtic leu-
kaemia, a known secretor of CSA, were
also tested for colony inhibition. These
cells did not suppress colony formation
and, at high cell concentrations without
HPCM, produced equivalent or more
colonies than were produced with HPCM.
Inhibition at high concentrations in
these experiments did not appear to be
due to poor culture conditions secondary
to nutrient depletion, as colony size was
not affected. Colonies of several hundred
cells each were regularly observed in
cultures containing 8 x 106 leukaemic cells,
even though leukaemic growth frequently
was not totally suppressed by the 05°/
agar overlayer.
As a further possible control against
nutritional depletion of 8 x 106 viable
cells beneath the underlayer, up to 8 x 106
normal peripheral blood cells were also
cultured in underlayers with and without
RPCM and with or without indomethacin.
Any inhibition observed at high cell con-
centrations of normal cells was eliminated
by the addition of indomethacin, suggest-
ing a prostaglandin mechanism as des-
cribed previously (Kurland et al., 1978)
and not a nutritional mechanism. It is
interesting to note that mononuclear cells
increased the stimulus over that observed
with HPCM alone (Fig. 2). All 9 experi-
Experiment
-A_-
3
33+1
14+1
0
4+ 1
0
0
0
0
()
4
:33+1
(
37+1
0
:30 + 3
2 + 0
37+2
9+ 1
:37 + 4
10+3
17+2
8+1
5t
:39+ 2
51 +4
11 + 1
47+6
:34+ 1
49+5
64+2
:3 + 6
59+:2
39+2
51 + I
6t
68+3
80+2
15 + 3
83 + 1
59+6
81 +4
74+ :3
72+ 1
62+2
69+5
60+1
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Fia. 2. Influence ofnormal peripheral-blood
cells with and without HPCM and indo-
methacin on colony formation of normal
nonadherent marrow cells. Varying num-
bers of normal peripheral-blood mono-
nuclear cells were cultured in agar under-
layers with HPCM (A) and with 10-6M
indomethacin (C]1) with both (*) and with
neither (0). Bars represent s.e. based on
3 plates.
ments previously described that showed
leukaemic inhibition of CFU-C growth
were also performed incorporating 10-6M
indomethacin and, unlike the results with
normal cells, showed no abolition of
marrow suppression. In some experiments
there was enhancement of suppression at
high cell doses, when indomethacin was
included in cultures. One such experiment
is shown in Table I. This is being further
investigated, but it appears certain that
prostaglandin synthesis andrelease are not
the mechanism of inhibition.
To determine whether cell division was
necessary for this suppression, leukaemic
cells were irradiated before culture. There
were no single cells or clusters in the under-
layers when cultures were scored on Day
7 or 14. Results from these experiments are
given in Fig. 3 (same leukaemic sample as
Fig. 1) and in Table II for the leukaemics
listed in Table I. In all cases in which
irradiation was used, it diminished or
abolished suppression, and enhanced
colony growth significantly in some experi-
ments. It did not destroy the ability of
leukaemic cells to produce CSA (Expt 5,
Table II).
If an inhibitor is produced by high con-
centrations of leukaemic cells, it should
be possible to detect such an inhibitor
by conditioning medium with leukaemic
cells, providing it is not too labile. Media
were conditioned for 1, 2, 3, or 7 days with
varying concentrations of leukaemic cells
(0.5-8 x 106/ml) and 0-2 ml of media was
placed in underlayers with HPCM. Effects
of growth on nonadherent marrow targets
were compared to those on cultures con-
taining HPCM alone. In no instance was
significant inhibition or stimulation of
marrow growth detected (Table III, and
other data not shown). No inhibitors or
TABLE II.-Irradiated leukaemic-cell modulation of CFU-C growth
No.
leukaemic
cells
(x 106)
c Experiment
C-
HPCM
0 + 39+2T
0
05 + 75±4
0
1.0 + 69+2
0
2-0 + 72 4
0
40 + 65±4
0
8-0 + 63± 1
0
t Pure monocytic leukaemia.
3 4 5t
112
0
112
0
104
4
80
31
49
46
43
44
33+1
0
28+1
0
15+1
0
22+5
0
28+2
0
31 +2
0
33 +1
0
53+1
2+1
42+3
5+1
46 + 4
10+2
53+3
26+5
51 +4
28+4
39+2
0
65+5
13+2
65 + 4
14 + 1
59+1
62+2
51 +4
59 +5
72+3
51+1
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TABLE IV.-Absorption of human placen-
tal-conditioned media (HPCM)
0
* 150
, 100
0 \
0 50
b
0.5 1 2 4 8
Number of Leukaemic Cells x 106
in the Agar Underlayer
Fia. 3.-Effect of irradiation of leukaemic
cells on inhibition ofnormal colony growth.
Normal marrow was cultured on leukaemic
cell underlayers that either had (A, A) or
had not (0, 0) been irradiated with 20 Gy
before culture in the underlayer. (Solid
symbols: Expt 1. Open symbols: Expt 2.)
TABLE III.-Effect of leukaemic-condi-
tioned media (Day 7) on normal marrow
(non-adherent) CFU-C growth in response
to CSA (No. of colonies (s.e.))
No.
leukaemic
cells to
condition Experiment
media _-A-_
(x 106) 1 2 3 4
0 (control) 12 (1) 71 (4) 105 (2) 11 (1)
0-5 11 (1) -
1 15 (1) -
2 11 (2) 64 (0)
4 9 (0-5)
8 12 (1) 79 (5) 116 (2) 16 (1)
Media conditioned by varying concentrations of
leukaemic cells for 7 days were added at a total
volume of 0-2 ml to underlayers of 0-5% agar with
optimal amounts of CSA (human placental-con-
ditioned media). The control medium was a-MEM
with 15% FCS and no cells
Source ofcells
0
Leukaemic A
Normal mononuclear
blood cells
Normal low-density
(< 1-077 g/ml)
marrow cells
Expt 1
17* (I)t
26 (2)
Expt 2
12 (2)
24 (2)
28 (2) 33 (2)
19 (2) 32 (1)
* No. colonies.
t s.e.
HPCM was absorbed with 108 cells/ml for 30 min
at 4°C. A volume of 0-1 ml was then added to the
underlayer and compared to unabsorbed HPCM
using 105 nonadherent, low-density (<1-077 g/ml)
human marrow cells as a target. Expts 1 and 2
represent different targets.
stimulators could be induced by including
PHA in the culture while media were
conditioned by leukaemic cells (data not
shown). An alternative explanation could
be that the high numbers of leukaemic
cells consumed CSA, though this appeared
unlikely in view of the normal colony size
noted when inhibition was seen. To test
this, we absorbed aliquots of HPCM with
108 cells/ml for varying periods at 4°C
or 37TC. Table IV shows the unexpected
results. The HPCM absorbed with leu-
kaemic cells, normal peripheral-blood
mononuclear cells, or normal marrow cells
caused higher colony growth than un-
absorbed HPCM. This phenomenon was
TABLE V.-Dose titrations of absorbed and
unabsorbed HPCM
Colony counts
HPCM
(ml)
0-025
0-05
0-1
0-2
0-3
- I
0-1 ml
Absorbed unabsorbed
HPCM at Absorbed HPCM+
4°C for HPCM at 0-2 ml
Unab- 60 min 4°C for absorbed
sorbed (A) 14 h (A)
0
5
10
53
12
45
53
210
220
140
90
180
180
270
85 235
Varying amounts of absorbed or unabosrbed
HPCM (except for one mixing experiment) were
placed in agar underlayers and 105 non-adherent,
low-density (< 1-077 g/ml) marrow cells were used
as a target in a 0-3% upper layer. Values are the
mean of 2 plates.
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not confined to this batch of HPCM, as
similar results occurred with other batches.
The enhancement was greater when ab-
sorption were continued for 60 min or
overnight (Table V). Contrary to expecta-
tions, the possibility that an inhibitor of
HPCM activity was absorbed was not
borne out. Titrations with both absorbed
and unabsorbed HPCM suggested that an
inhibitor might be present in both prepara-
tions at the same volume of 0 3 ml, and
mixing unabsorbed and absorbed HPCM
did not suppress colony formation below
that obtained with absorbed HPCM alone
(Table V).
DISCUSSION
These experiments show that leukaemic
cells from some patients, when cultured
in underlayers, can inhibit normal marrow
myeloid colony growth. This inhibition
occurs regularly only at high leukaemic
cell concentrations (4-8 x 106 cells culture)
much greater than the concentrations
reported to cause inhibition in co-culture
experiments by other authors (Chiyoda
et al., 1975; Craddock et al., 1978; Cordon
et al., 1978; Knudtson & Mortenson, 1976;
Morris et al., 1975). In fact, at low cell
concentrations we frequently found stimu-
lation ofnormal colony growth, despite the
fact that these same leukaemic cell con-
centrations did not stimulate colony
formation when used in underlayers with-
out HPCM. A possible explanation for the
difference between our observations and
those of other reported co-culture experi-
ments is that the culture conditions or
CSA sources in the other studies were
suboptimal. The other authors used lower
criteria for colony size, which suggested
poorer colony growth. In Chiyoda's work
2 x 105 cells gave 16 4 + 2 4 colonies (mean
+ s.e.). This is about 10-25% of the
figures obtained in our laboratory. Under
suboptimal conditions, CFU-C may be
more sensitive to leukaemic inhibitors.
Other possible explanations for the dis-
crepancy between the cell doses required
include some intermediary inhibitor cell
when feederlayers are used, or alterna-
tively moreshort-range humoralinhibitors,
only demonstrated when leukaemic cells
are used in the overlayer.
It is unlikely that our results are due to
poor culture conditions secondary to con-
sumption of nutrients at higher cell con-
centrations. Colony size was not affected,
a finding that has always been seen with
poor culture conditions. Also, normal
peripheral-blood mononuclear cells with
indomethacin or pure monocytic leukaemic
cells capable of releasing CSA did not
suppress colony growth. Indomethacin did
not abolish this leukaemic suppression,
which rules out prostaglandin as the
mechanism. This suppression probably
required some cell division, for steriliza-
tion with radiation abolished it.
We expected that, if such suppression
was demonstrable in agar culture, a
soluble factor affecting this inhibition
should be detected by allowing viable
leukaemic cells in varying concentrations
to condition media. This idea was sup-
ported by Broxmeyer's finding of a so-
called luekaemic inhibitory activity (LIA),
which can suppress CFU-C and can be
detected in leukaemic extracts or leu-
kaemic-conditioned media. Despite many
attempts with cells from 4 leukaemic
patients, including cells showing inhibition
of CFU-C growth in co-culture experi-
ments, we have not been able to detect
such an inhibitor in conditioned media.
Bull et al. (1973) have suggested that
leukaemic cells, in response to HLA-
differing marrow, release inhibitory fac-
tors. Though mixtures of normal marrow
do not show suppression (Chiyoda et al.,
1975; Morris et al., 1975) this does not
totally rule out the possibility. Also, using
different target cells on the same leukaemic
patient underlayers, suppression at high
cell doses was within a narrow range,
an unusual finding if HLA differences
accounted for these results.
In the course of these investigations,
other unexpected interactions in leukaemic
and normal haematopoiesis were dis-
covered. First, irradiation of leukaemic
cells before their incorporation into agarAML-MYELOID COLONY INTERACTIONS 155
culture frequently enhanced the growth of
myeloid CFU-C over growth with HPCM
alone. The HPCMs we have are routinely
more active than human peripheral mono-
nuclear cells, and probably represent the
optimal reproducible system for growth
of human myeloid CFU-C (Verma et al.,
1980). Secondly, absorption of HPCM at
4°C improved HPCM activity markedly
over that at 37°C. This was not due to
removal ofinhibitor, andtheimprovement
in activity was not specific to leukaemic
absorption. It is conceivable that HPCM
could interact with the cell membrane, be
altered in biochemical composition, and
then come offthe cell membrane in a more
active form. Absorption at 37°C might be
associated with production of proteases,
and breakdown ofthis more active moiety.
Irradiated cells in culture may alter
HPCM in a similar way, enhancing cell
growth. Metabolism may not be necessary
for this membrane interaction. Unirradia-
ted leukaemic cells could show variable
effects, depending upon secretion of CSA
or possible inhibitors, possible favourable
alterations in the CSA molecule, and the
release of enzymes that could break down
this favourably altered CSA. Because of
the favourable effects of leukaemic addi-
tion to agar culture, inhibition may not be
detected until enough leukaemic cells are
added to secrete significant amounts of
inhibitors. Obviously, the interactions of
leukaemic cells with CFU-C are far from
understood and require much more in-
vestigation. Lastly, it may not even occur
at the level of the myeloid CFU-C, but
at earlier stages in haemopoiesis. These
results may therefore merely represent
interesting in vitro findings.
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